Pharmaceutical Investing FDA Approves SEYSARA (Sarecycline) for the Treatment of Moderate to Severe Acne
Pharmaceutical Investing Paratek Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Omadacycline New Drug Applications
LaFleur Minerals Provides Update on Beacon Mill Restart, Results of Annual General and Special Meeting, and Swanson Gold Deposit Exploration and Drilling Updates
